| Product Code: ETC6962446 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Denmark saw significant imports of large molecule drug substances from top countries including Spain, USA, Belgium, Germany, and the UK. The market remained concentrated with a high Herfindahl-Hirschman Index (HHI). Despite a notable compound annual growth rate (CAGR) of 29.58% from 2020 to 2024, there was a decline in growth rate from 2023 to 2024 at -37.88%. This data suggests a dynamic and evolving landscape for large molecule drug substance imports in Denmark, with potential shifts in market dynamics and supplier relationships.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Denmark Large Molecule Drug Substance CDMO Market Overview |
3.1 Denmark Country Macro Economic Indicators |
3.2 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Denmark Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Denmark Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Denmark Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for biologics and large molecule drugs |
4.2.2 Growing trend towards outsourcing drug substance manufacturing |
4.2.3 Technological advancements in large molecule drug manufacturing processes |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for manufacturing large molecule drug substances |
4.3.2 High initial setup costs for establishing large molecule drug manufacturing facilities |
5 Denmark Large Molecule Drug Substance CDMO Market Trends |
6 Denmark Large Molecule Drug Substance CDMO Market, By Types |
6.1 Denmark Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 Denmark Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Denmark Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 Denmark Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Denmark Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Denmark Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Denmark Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Denmark Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Average turnaround time for drug substance manufacturing projects |
8.2 Number of successful technology transfer projects completed |
8.3 Percentage of repeat business from existing clients |
9 Denmark Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Denmark Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Denmark Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Denmark Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Denmark Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Denmark Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Denmark Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here